Alexa Kimball
Chief Executive Officer & President Harvard Medical Faculty Physicians
Bio here.
Seminars
Thursday 20th November 2025
Panel Discussion: Bridging Science and Strategy: Funding the Next Wave of Dermatology Innovation
9:00 am
- Trends in capital allocation across indications, modalities, and stages of development in dermatology
- Key factors that shape investor and pharma conviction in early-stage assets and platforms
- How clinical trial design, endpoints, and market access considerations influence fundability
- Strategies for building successful partnerships and aligning with pharma and investor expectations
Thursday 20th November 2025
Panel Discussion: Bridging Science and Strategy: Funding the Next Wave of Dermatology Innovation
9:00 am
- Trends in capital allocation across indications, modalities, and stages of development in dermatology
- Key factors that shape investor and pharma conviction in early-stage assets and platforms
- How clinical trial design, endpoints, and market access considerations influence fundability
- Strategies for building successful partnerships and aligning with pharma and investor expectations
Wednesday 19th November 2025
Keynote: Shaping The Future of Skin Therapeutics: Clinical Momentum & Strategic Innovation
8:00 am
- Evaluating progress in dermatological therapies by reviewing approved products and late-stage clinical assets in conditions like acne, atopic dermatitis, and psoriasis
- Exploring market potential in underserved segments of dermatology, including paediatric patients, rare inflammatory diseases, and post-biologic maintenance strategies
- Evaluating tools with the most promise for the future: from AI, synthetic biology platforms, and scalable topical manufacturing to unlock next-gen innovations
Wednesday 19th November 2025
Keynote: Shaping The Future of Skin Therapeutics: Clinical Momentum & Strategic Innovation
8:00 am
- Evaluating progress in dermatological therapies by reviewing approved products and late-stage clinical assets in conditions like acne, atopic dermatitis, and psoriasis
- Exploring market potential in underserved segments of dermatology, including paediatric patients, rare inflammatory diseases, and post-biologic maintenance strategies
- Evaluating tools with the most promise for the future: from AI, synthetic biology platforms, and scalable topical manufacturing to unlock next-gen innovations
